Conference
Phase II multicenter open‐label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies
Abstract
The results of a multicenter phase II study investigating carboplatin and pegylated liposomal doxorubicin (PLD) in patients with recurrent/metastatic uterine and cervical malignancies (UCM) are presented here. Fifty-three subjects with measurable, untreated, advanced UCM were enrolled. Fifty-one were evaluable for response. Prior combined-modality treatment was permitted if a component of primary therapy. Patients received carboplatin AUC = 5 …
Authors
LÊ LH; SWENERTON KD; ELIT L; PROVENCHER DM; STUART GCE; LE T; LEE U; RODGERS A; POND GR; HU H
Volume
15
Pagination
pp. 799-806
Publisher
Elsevier
Publication Date
September 2005
DOI
10.1111/j.1525-1438.2005.00139.x
Conference proceedings
International Journal of Gynecological Cancer
Issue
5
ISSN
1048-891X